Menu Search
Equities

Pulmonx Corp

LUNG:NSQ

Pulmonx Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)6.79
  • Today's Change0.37 / 5.76%
  • Shares traded257.89k
  • 1 Year change-35.94%
  • Beta0.6916
Data delayed at least 15 minutes, as of Nov 22 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Pulmonx Corp had net income fall 3.26% from a loss of 58.92m to a larger loss of 60.84m despite a 27.98% increase in revenues from 53.66m to 68.68m.
Gross margin74.16%
Net profit margin-72.01%
Operating margin-73.40%
Return on assets-32.41%
Return on equity-51.99%
Return on investment-36.42%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Pulmonx Corp fell by 18.18m. Cash Flow from Financing totalled 21.40m or 31.16% of revenues. In addition the company used 37.61m for operations while cash used for investing totalled 2.01m.
Cash flow per share-1.43
Price/Cash flow per share--
Book value per share2.38
Tangible book value per share2.32
More ▼

Balance sheet in USDView more

Pulmonx Corp appears to have little financial risk as the company holds a substantial amount of cash on its books. In fact, 0.33% of the market capitalization can be attributed to its 83.55m and debt could be paid in full if management chose.
Current ratio7.70
Quick ratio6.77
Total debt/total equity0.3964
Total debt/total capital0.2839
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.